Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sasha J. Beyer"'
Autor:
Haley K. Perlow, MD, Jennifer K. Matsui, PhD, Ashlee Ewing, CMD, Catherine Cadieux, CMD, Khaled Dibs, MBBS, Rituraj Upadhyay, MD, Dukagjin M. Blakaj, MD, PhD, Sasha J. Beyer, MD, PhD, Evan M. Thomas, MD, PhD, John C. Grecula, MD, Raju R. Raval, MD, DPhil, Joshua D. Palmer, MD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 3, Pp 101424- (2024)
Introduction: Craniospinal irradiation (CSI) is indicated for adult patients diagnosed with leptomeningeal disease (LMD). Proton-based vertebral body sparing (VBS) CSI has been explored with pediatric patients to minimize hematologic toxicity; howeve
Externí odkaz:
https://doaj.org/article/f24d7cfc3ff042bca993a666d23e6ea0
Autor:
Rituraj Upadhyay, Brett G. Klamer, Haley K. Perlow, Julia R. White, Jose G. Bazan, Sachin R. Jhawar, Dukagjin M. Blakaj, John C. Grecula, Andrea Arnett, Mariella A. Mestres-Villanueva, Erin H. Healy, Evan M. Thomas, Arnab Chakravarti, Raju R. Raval, Maryam Lustberg, Nicole O. Williams, Joshua D. Palmer, Sasha J. Beyer
Publikováno v:
Cancers, Vol 16, Iss 1, p 137 (2023)
Background: Breast cancer is the second most common cause of brain metastases (BM). Despite increasing incidence of BM in older women, there are limited data on the optimal management of BM in this age group. In this study, we assessed the survival o
Externí odkaz:
https://doaj.org/article/1e59e28411e64d82a232290bde0c4299
Publikováno v:
Biomedicines, Vol 11, Iss 1, p 98 (2022)
Many patients with non-metastatic breast cancer benefit from adjuvant radiation therapy after lumpectomy or mastectomy on the basis of many randomized trials. However, there are many patients that have such low risks of recurrence after surgery that
Externí odkaz:
https://doaj.org/article/2f82c9ac32ca4681abe857f727b1befe
Autor:
Jennifer K. Matsui, Haley K. Perlow, Rohit K. Raj, Ansel P. Nalin, Eric J. Lehrer, Rupesh Kotecha, Daniel M. Trifiletti, Shearwood McClelland, Kari Kendra, Nicole Williams, Dwight H. Owen, Carolyn J. Presley, Evan M. Thomas, Sasha J. Beyer, Dukagjin M. Blakaj, Manmeet S. Ahluwalia, Raju R. Raval, Joshua D. Palmer
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2211 (2022)
Brain metastases are a devastating sequela of common primary cancers (e.g., lung, breast, and skin) and have limited effective therapeutic options. Previously, systemic chemotherapy failed to demonstrate significant benefit in patients with brain met
Externí odkaz:
https://doaj.org/article/31c7faf82cdd4e0a9e90aedf5f123866
Autor:
Jennifer K. Matsui, Haley K. Perlow, Alex R. Ritter, Rituraj Upadhyay, Raju R. Raval, Evan M. Thomas, Sasha J. Beyer, Clement Pillainayagam, Justin Goranovich, Shirley Ong, Pierre Giglio, Joshua D. Palmer
Publikováno v:
Biomedicines, Vol 10, Iss 7, p 1763 (2022)
Glioblastoma (GBM) is an aggressive primary brain tumor that is associated with a poor prognosis and quality of life. The standard of care has changed minimally over the past two decades and currently consists of surgery followed by radiotherapy (RT)
Externí odkaz:
https://doaj.org/article/9967987f81e940d482489b8b190eb573
Autor:
Jennifer K. Matsui, Haley K. Perlow, Rituraj Upadhyay, Aliah McCalla, Raju R. Raval, Evan M. Thomas, Dukagjin M. Blakaj, Sasha J. Beyer, Joshua D. Palmer
Publikováno v:
Surgical Oncology Clinics of North America. 32:569-586
Autor:
Kamran A. Ahmed, Youngchul Kim, Michelle DeJesus, Sasha J. Beyer, Nicole O. Williams, Joshua Palmer, Kristina D. Woodhouse, Rashmi K. Murthy, Jing Li, Avan J. Armaghani, John A. Arrington, Ricardo L. Costa, Brian J. Czerniecki, Arnold B. Etame, Peter A. Forsyth, Hung T. Khong, Daniel E. Oliver, Marilin Rosa, Solmaz Sahebjam, Hatem H. Soliman, Aixa E. Soyano, Michael A. Vogelbaum, Michael Yu, Hyo S. Han
Publikováno v:
Cancer Research. 82:OT2-09
Background: Breast cancer patients with brain metastases have a high unmet clinical need and improved management strategies are needed. There has been interest in studying CDK 4/6 inhibitors in the management of breast cancer brain metastases. A phas
Autor:
Sasha J, Beyer, Erica H, Bell, Joseph P, McElroy, Jessica L, Fleming, Tiantian, Cui, Aline, Becker, Emily, Bassett, Benjamin, Johnson, Pooja, Gulati, Ilinca, Popp, Ori, Staszewski, Marco, Prinz, Anca L, Grosu, Saikh Jaharul, Haque, Arnab, Chakravarti
Publikováno v:
Oncotarget
The presence of an isocitrate dehydrogenase (IDH1/2) mutation in gliomas is associated with favorable outcomes compared to gliomas without the mutation (IDH1/2 wild-type, WT). The underlying biological mechanisms accounting for improved clinical outc